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Abstract 
Aims and objectives. To measure renal nurses’ perceptions on assessing medication adherence 
in patients undergoing dialysis.  
Background. Renal nurses play a vital role in caring for patients undergoing dialysis. Despite 
the high prevalence of medication nonadherence in chronic dialysis patients, little is known 
about renal nurses’ perceptions and current adherence assessment practices.  
Design. A cross-sectional survey.  
Methods. Participants completed an online survey between March and May 2016. Five 
psychometric scales were used to measure perception on prevalence and contributors of 
nonadherence, effective methods of assessment, barriers to assessment, and confidence to 
assess adherence. The survey also captured current adherence assessment practices using a 
four-point graded response (1 = do not practice at all to 4 = practice for every patient).  
Results. A total of 113 dialysis nurses completed the survey. The majority agreed that patients 
in their unit are nonadherent to their medicines (74.5%, n = 82; median = 8). Most nurses agreed 
that having dedicated professionals conducting medication history interviews can be effective 
in identifying nonadherence (88.9%, n = 96; median = 8). Objective assessment through blood 
results was the most frequently used method to determine nonadherence (83.2%, n = 89), with 
little attention being paid to patients’ self-reports of adherence (55.1%, n = 59). Time 
constraints, administrative support, and patients’ disinterest in discussing medication-rela ted 
issues with the nurses were perceived as barriers to assessing adherence.  
Conclusions. Patient self-reported measures to assess adherence were under-utilised by the 
renal nurses, whereas objective blood monitoring was routinely used. Overcoming dialys is 
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nurses’ work-related barriers may facilitate the effective monitoring and promotion of 
medication adherence in chronic dialysis patients. 
Relevance to clinical practice. Results from this study emphasize the need for proper 
assessment of dialysis patient’s medication-taking behaviour during routine dialysis to ensure 
the benefits of prescribed therapies.  
 
Key words  
adherence assessment practices, cross-sectional survey, dialysis, chronic kidney failure, 
medication adherence, renal nurses  
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Introduction 
Medication nonadherence often leads to poor patient outcomes in chronic diseases (Ingersoll 
& Cohen, 2008). The negative impact of nonadherence is such that alleviating it  would result 
in greater public health gains than developing newer, costly therapies (Ingersoll & Cohen, 
2008; Sabaté, 2003). The reasons for nonadherence depend on the disease and the complexity 
of the regimens prescribed (Osterberg & Blaschke, 2005). Chronic kidney disease (CKD) 
patients in general, and patients receiving dialysis in particular, are at high risk of medication 
nonadherence. This may be due to an increased burden of concomitant illness and dialysis-
related problems, leading to an increased complexity of various treatment regimens (Ghimire, 
Peterson, Castelino, Jose, & Zaidi, 2016). In general, 50% of the patients undergoing dialys is 
do not adhere to part of their treatment regimen, with nonadherence to medication ranging 
between 12.5% and 98.6% (Ghimire, Castelino, Lioufas, Peterson, & Zaidi, 2015; Kammerer, 
Garry, Hartigan, Carter, & Erlich, 2007). The worsening of the underlying illness in patients 
undergoing dialysis following medication nonadherence has been associated with increased 
mortality and repeated hospitalizations, placing a substantial financial burden on the healthcare 
system (Ghimire et al., 2015).  
 
Background 
The current research on medication adherence primarily focuses on understanding and 
changing the medication-taking behaviour of patients, rather than on understanding and 
changing the healthcare system inadequacies that may affect adherence in patients (Clyne et 
al., 2016; Mangan, Powers, & Lengel, 2013). Patients who had  shorter consultations with their 
doctor or a healthcare professional that lacked a discussion on medication-related issues were 
found to be  nonadherent  to their prescribed treatment (Rifkin et al., 2010; Williams, Manias, 
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& Walker, 2008). Engaging patients in a meaningful conversation about their medication use 
may not be a straightforward solution to this problem. Healthcare professionals have reported 
time availability and work pressures as barriers to assessing a patient’s ability to take 
medications, and to investigating any impediments to medication adherence (Williams et al., 
2008).  
Despite extensive research on the incidence, measurement, and improvement of 
medication adherence (Osterberg & Blaschke, 2005), little is known about the actual practices 
of measuring adherence in clinical settings. The extent to which renal nurses are aware of 
adherence measurement practices, and how much time is devoted to measuring and promoting 
adherence in patients undergoing dialysis, is unknown. Renal nurses working with patients get 
to know them well as they see them frequently, usually three times a week for a period of three-
to-five hours a day. Such level of engagement provides an exceptional opportunity for the 
dialysis nurses to educate and promote medication adherence in patients undergoing dialysis.  
Nevertheless, an understanding of dialysis nurses’ perceptions of adherence assessment 
practices, and the likely barriers to monitoring, and improving medication adherence is 
essential before nurses can take part in any quality initiative targeting nonadherence. Therefore, 
this study was designed to understand renal nurses’ perceptions on medication adherence 
assessment practices in patients undergoing dialysis.  
 
Methods 
Study design 
An online cross-sectional survey method was used. We followed the STROBE guidelines for 
the design and  reporting of this research (Vandenbroucke et al., 2007).  
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Setting and participants  
All dialysis nurses practising in Australian dialysis settings were eligible to participate. We 
recruited participants through the professional renal association, the Renal Society of 
Australasia (RSA) as recruiting them directly was not practicable due to absence of guaranteed 
means of identifying renal nurses individually.  
 
Data collection 
An online survey was conducted for a period of three months between March and May, 2016. 
We coordinated with the professional association to send information that described the study’s 
aims, and which gave a web address for the survey, to dialysis nurses through email alerts, 
social media posts, and e-newsletters. Reminders were sent on a fortnightly basis. After the 
survey was completed, we randomly selected eight participants who had opted in to win gift 
vouchers valued at AUD $100. Although offering incentives to respond has been found to 
influence survey response (Eleanor & Cong, 2012), the draw amount was insignificant for the 
nursing professionals, and our intention was mainly to thank participants for their contribut ion.  
 
Survey instrument 
During the thorough literature search, we could not identify any validated tools that particula r ly 
measured dialysis nurses’ perceptions regarding adherence assessment practices. Hence we 
adapted a previously developed survey instrument that measured renal pharmacists’ 
perceptions and practices of assessing adherence in dialysis settings (Ghimire, Banks, Jose, 
Castelino, & Zaidi, 2017). To briefly describe the instrument, it comprised seven sections that 
explored demographics, perceptions of the prevalence of, and contributors to nonadherence, 
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the perceived effectiveness of methods used to detect nonadherence, barriers to adherence 
assessment, and participants’ confidence in assessing adherence. A 10-point Likert scale of 
agreement was used to measure perception (1 = strongly disagree, 10 = strongly agree). The 
last section comprised questions related to the current practices of assessing adherence in 
dialysis patients, and used four-point graded response where one meant “do not practice at all”, 
and four meant “practice for every patient”.  
 
Statistical analysis 
Data were entered and analysed in SPSS version 23.0 (IBM Corp., Armonk, N.Y., USA). 
Demographic characteristics were ascertained through descriptive analysis. Kolmogorov-
Smirnov and Shapiro-Wilks tests were performed to assess normality. Perception scores were 
summarised using the median and the inter quartile range (IQR). Mann-Whitney or Kruskal-
Wallis tests was performed to detect the differences in median scores for non-normally 
distributed data. The Dunn-Bonferroni test was used to identify statistically significant 
differences between intergroup variables as a post-hoc analysis (Dunn, 1964). Cronbach’s 
alpha coefficient was used to measure the internal consistency reliability of the perception 
scales. A p value of < 0.05 was considered statistically significant.  
 
Ethics 
Ethics approval was granted by the Tasmanian Social Sciences Human Research Ethics 
Committee (reference number: H0015433).  
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Results 
A total of 113 renal nurses completed the survey. The majority of the participants were female 
(92.0%, n = 104), with 11-20 years of experience in renal units (47.8%, n = 54). As participants 
were recruited indirectly through the RSA, which has over 1800 members, including nurses, 
technicians, social workers, dietitians, and other allied health professionals, we could not gauge 
the actual survey response rate for renal nurses alone. Nevertheless, this study was not aimed 
at generalisability, but for developing and piloting the survey instrument to inform larger 
nation-wide studies in dialysis settings. The  characteristics of the respondents are presented in 
Table 1. 
 
Internal consistency and reliability of scales 
The overall reliability comprising all five scales demonstrated a good level of interna l 
consistency, with an alpha score of 0.84. The following were the reliability coefficients for 
each scale: perceived prevalence scale (0.85), perceived contributors (0.83), perceived 
effectiveness (0.67), perceived barriers (0.70), and participant confidence (0.90). Appendix 1 
contains the particulars of the Inter-Item Correlation Matrix, and Cronbach’s alpha coefficients 
for each scale.  
 
Perceived prevalence and contributors of nonadherence 
The majority of renal nurses believe dialysis patients in their unit often forget to take their 
medicines (median = 8), rarely ask questions about medicines (median = 7), are unable to 
answer medicine-related questions (median = 7), and are often confused about their medicines 
(median = 7). The majority of the nurses thought that having limited understanding of their 
disease (median = 7), being prescribed with complex medication regimens (median = 7), 
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lacking family or social support (median = 7), having low educational backgrounds (median = 
7), and low income (median = 7) contributed to medication nonadherence in dialysis patients. 
The majority of the participants disagreed that being older (median = 4) or male (median = 5) 
contributed to nonadherence behavior, however (Table 2).    
 
Perceived effectiveness and barriers to assessing adherence  
The majority of renal nurses agreed that having dedicated professionals who take medication 
histories (median = 8), or having pharmacists who conduct medication reviews and 
reconciliations (median = 9) can be effective in assessing adherence. High median ratings were 
also observed for the effectiveness of assessing adherence through objective methods, such as 
blood results or physical assessment (median = 8), and through subjective methods, such as 
conducting medication history interviews (median = 8).  
Renal nurses disagreed that they lacked the knowledge and skills to assess adherence 
(median = 2), but over one-third perceived that they lacked the time needed to undertake 
adherence promoting activities (median = 4). Furthermore, over a third of the participants 
reported that they lacked administrative support from hospital in conducting adherence 
promoting activities (median = 5). Nearly a quarter of the nurses also perceived that patients 
are not interested in discussing medication-related issues with them (median = 3) (Table 3).  
 
Participants’ confidence in assessing adherence 
Dialysis nurses’ median confidence ratings were higher in terms of ability to suggest strategies 
to improve adherence (median = 8), followed by ability to assess patients’ knowledge and 
beliefs about medicines (median = 8), conduct a medication history interview (median = 8), 
and provide medication counselling (median = 8) (Table 3).  
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Differences in perceptions based on study demographics    
Participant age significantly affected their median scores on perceived barriers (χ2 (3, N = 108) 
= 11.52, p < 0.01). Younger nurses aged 20-30 years perceived more barriers than their elder 
counterparts aged 41-50 years (median: 5 vs 2, p < 0.05), and ≥ 51 years (median: 5 vs 2, p < 
0.05). Similarly, significant differences were observed in perceived contributor scores based 
on professional designation (χ2 (2, N = 108) = 6.76, p < 0.05). Registered nurses perceived 
more contributors to nonadherence than the nurse unit managers (median: 7 vs 5, p < 0.05). 
Participants’ experiences in renal units also influenced their confidence scores (χ2 (2, N = 108) 
= 6.21, p < 0.05). Nurses with 1-10 years of experience were less confident in assessing 
adherence than participants with 11-20 years (median: 7 vs 8, p < 0.05), and with ≥ 21 years 
(median: 7 vs 8, p < 0.05) of experience (Table 4).  
 
Current practices of assessing adherence  
Figure 1 depicts the renal nurses’ reports on current adherence assessment practices in dialys is 
centres. Assessing adherence objectively through blood results or physical assessment was 
routinely conducted for every patient (83.2%, n = 89). The majority of the participants reported 
that pharmacists were not available for medication reviews and reconciliation activities (65.1%, 
n = 69), and almost half of the participants mentioned that dedicated professionals were not 
assigned to conducting medication history interviews (46.7%, n = 49). Similarly, only around 
half of the participants (55.1%, n = 59) reported that medication history interviews were 
conducted for every patient. Patients’ families or carers were asked about medication only 
when those patients were thought to have a high risk of adverse effects (45.8%, n = 49). 
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Similarly, asking patients to bring medications and counting them was mainly practiced in high 
risk patients (33.0%, n = 35).  
 
Qualitative comments  
The qualitative comments reinforced the survey findings regarding contributors of 
nonadherence, such as lack of knowledge about medicines, comorbid illnesses, tablet burden, 
culture and communication barriers, lack of  support, forgetfulness, and relative affordability 
of medicines. Nurses also highlighted the need for a sustainable strategy to empower self-
management in patients taking long-term medications. There was a recurring theme in the 
desire for a designated renal pharmacist in dialysis settings to manage medication-rela ted 
issues. Furthermore, nurses reported that patients trusted their doctors with medical decisions, 
and preferred communicating with them rather than with the nurses. Due to long waiting times 
for consultations, however, their medication-related queries remain unanswered. This 
subsequently nurtured nonadherence behaviour in patients undergoing dialysis. The comments 
are given in Appendix 2.  
 
Discussion 
We reported renal nurses’ perceptions on assessing medication adherence in patients 
undergoing dialysis. The  internal consistency and reliability of the overall scale was good. The 
findings from this study suggest that current adherence assessment practices are suboptima l, 
and the methods used to screen patients’ medication-taking behaviour are used less in dialys is 
settings. Renal nurses seemed to be confident in conducting adherence assessment activit ies, 
and their level of confidence increased with increased work experience. Lack of time, lack of 
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support from hospitals, and patients’ disinterest in discussing medication-related issues with 
the nurses were perceived as barriers to assessing adherence. The majority of the nurses 
acknowledged that having a dedicated pharmacist would be effective in promoting adherence 
activities, but these services are rarely available in dialysis centres.  
 
Nurses’ perceptions on medication nonadherence in dialysis patients  
Health professionals are often overly optimistic about adherence behaviour in their patients 
(Patel & Davis, 2006), however, renal nurses in this study acknowledged the high prevalence 
of nonadherence behaviour in patients undergoing dialysis. Although adherence to any 
treatment regimen is a subject of maximum interest, one must not forget the reason why many 
patients do not adhere to their medications as prescribed. Often this might be an avoidance 
coping strategy, whereas at other times this might be due to ignorance. As each individua l 
presents with a unique set of circumstances, efforts must be made to understand the reasons 
behind nonadherence. Renal nurses’ perceptions, in this study, corroborated with earlier 
findings that patient-related factors, such as lack of knowledge about medicines, lack of social 
support, comorbid conditions, forgetfulness, medication burden, affordability, and culture and 
communication barriers could influence adherence (Brar, Babakhani, Salifu, & Jindal, 2014; 
Griva et al., 2013; Lindberg & Lindberg, 2008; Manley et al., 2004).  
 
Current adherence assessment practices 
We observed that current adherence assessment practices are limited, and that the methods used 
to monitor nonadherence behaviour, such as medication history taking, and medication reviews 
and reconciliation by pharmacists, were only occasionally conducted, whereas objective blood 
monitoring was a routine practice in most settings. A recent survey on renal pharmacists’ 
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perceptions corroborated the study’s findings on current adherence assessment practices in 
dialysis settings (Ghimire et al., 2017). Objective blood monitoring in patients undergoing 
dialysis is mainly conducted to ensure that the dialysis prescription, i.e the time and type of the 
dialysis treatments, are optimal. Although we can also draw inferences from blood results to 
see if patients are adherent to their medications, particularly, phosphate binders, the reliability 
of these results can be questioned as they can be affected by various dietary and clinical factors. 
A preferable approach would be to combine objective measures with subjective ones, such as 
patient interviews or validated adherence assessment questionnaires (Brar et al., 2014).  This 
may also help to overcome the subjective bias of patient self-reports (Hsu et al., 2015; Wileman 
et al., 2014). 
 
Barriers to adherence assessment practices 
The ability to conduct adherence assessments and promotion activities in dialysis centres may 
largely depend upon overcoming the barriers recognized in this study, such as time and 
resource limitations, a lack of hospital support, and most importantly unwillingness from both 
patients aand health professionals to actively participating in discussions to resolve medicatio n-
related issues. The delivery of adherence support activities by renal healthcare professiona ls 
will also depend upon the knowledge and skills they acquire through tailored education and 
training, and routine practices (Bajorek et al., 2015; Dayer, Dunn, Pace, & Flowers, 2016). 
Dialysis nurses in this study largely disagreed that they lack the knowledge and skills 
needed to conduct adherence assessment activities, and were instead highly confident about 
this. The fact that dialysis nurses are involved in managing and assessing the health needs of 
the patients on a daily basis, and in educating patients about their diseases, prognoses, and 
treatments may have contributed to higher confidence scoring. Expectedly, the majority of the 
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renal nurses also endorsed the inclusion of dedicated professionals, especially renal 
pharmacists, in undertaking adherence assessment activities in patients undergoing dialys is. 
Positive perceptions towards pharmacists’ roles may be due to past experiences of 
interprofessional collaborations, and awareness of the competency and contribution of 
pharmacists in delivering pharmaceutical care services (Chevalier & Neville, 2011; Salgado, 
Moles, Benrimoj, & Fernandez-Llimos, 2013; Sulick & Pathak, 1996). Interventions by the 
pharmacists have resulted in reduced hospitalisation, improved patient satisfaction, and 
reduced overall treatment expenses in patients undergoing dialysis (Salgado, Moles, Benrimoj, 
& Fernandez-Llimos, 2012). 
 
Integrating adherence assessment practices within nursing roles 
The availability of renal pharmacy services in Australian outpatient dialysis centres is 
extremely limited (Salgado et al., 2012). Centres receiving pharmacy services on “as 
necessary” basis might call upon pharmacists for medication reviews only on occasions when 
a patient’s condition is severe and demands inspection of their medication regimen. Although 
the presence of a dedicated professional or renal specialised pharmacist who can exclusive ly 
focus on medication management and adherence promoting activities would be an ideal 
solution, it is unlikely that this will be integrated into every dialysis centre anytime soon due 
to time and resource availability (Mangan et al., 2013), finances, and organizational factors 
(Roberts, Benrimoj, Chen, Williams, & Aslani, 2006; Salgado et al., 2012). Alternat ive 
measures include empowering the existing renal nursing services within the dialysis centres as 
they are the professionals who closely engage with the patients, and are ideally placed to deliver 
medicines, monitor patient progress, and educate patients in medication self-management to 
promote adherence (Emsley et al., 2015; Kammerer et al., 2007). Nevertheless, the existing 
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workload of the dialysis nurses and the barriers to successful incorporation of auxiliary roles, 
such as adherence assessment and promotion activities, need to be carefully considered in 
dialysis settings.  
 
Implications for nursing practice 
A recent systematic review of trials that assessed the effects of nursing interventions on 
improving medication adherence among discharged, home-dwelling, and older adults 
suggested that nurse-led and nurse-collaborative interventions moderately improved 
medication adherence in discharged older adults (Verloo, Chiolero, Kiszio, Kampel, & 
Santschi, 2017). Similarly, a nurse-delivered, self-care intervention program for chronic heart 
failure patients has been found to be effective in improving patients’ adherence (Granger et al., 
2015). Designing nurse-led tailored interventions suitable for use during dialysis sessions that 
educate patients on problem-solving, guide behavioural change, and teach them to take action 
in response to wavering signs and symptoms, can be an effective self-management strategy for 
improving medication adherence in patients undergoing dialysis (Lindberg & Lindberg, 2008). 
Renal nurses, in this study, also emphasised that sustainable strategies for empowering 
self-management in patients taking long-term medications, and having trusted relationships 
with healthcare providers, can have a significant influence on patients’ adherence. Patients 
become truthful about taking medication only if they are comfortable to admit their difficult ies 
with no risk of criticism, and when there is a true partnership with their healthcare providers 
(Martin, Williams, Haskard, & Dimatteo, 2005). Patients with CKD who express 
dissatisfaction due to an absence of guidance and a lack of discussion about medication-rela ted 
issues during consultations are found to be less motivated to follow treatment 
recommendations, to hide their concerns, and to acquire nonadherence behaviours (Rifkin et 
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al., 2010). Therefore, it is imperative that renal healthcare professionals routinely instiga te 
discussions on medication-related issues with the patients undergoing dialysis. 
 
Study limitations 
Participants were not directly recruited, instead email alerts, e-newsletters, and social media 
posts from the professional organization were relied upon. As such, an absolute denomina tor 
for the survey response rate could not be ascertained. This may have led to the inclusion of 
self-selected participants who were more interested in sharing their perceptions. Nevertheless, 
an even amount of participation was observed from rural and metropolitan areas, as well as 
from public and private dialysis centres. The study findings may not be generalisable to dialys is 
settings across Australia, for example, New South Wales has the highest number of dialys is 
centres, but there was poor representation from the renal nurses. Nevertheless, the scope of this 
study was mainly generate baseline observations to inform larger nation-wide surveys.   
 
Conclusions 
Clinicians spend a great deal of time prescribing the best possible medications for their patients, 
yet little attention is paid to measuring adherence and ensuring that patients are adhering to 
their prescribed medications. The current adherence assessment practices of renal nurses are 
limited to selective patients utilising objective laboratory-based values instead of patient self-
reported measures. Lack of time, administrative support, and patient disinterest in 
communicating medication issues with the renal nurses, were commonly perceived as barriers 
to assessing adherence. Strengthening renal nursing services by addressing the existing barriers 
may be a way to improve medication adherence in patients undergoing haemodialysis.   
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Relevance to clinical practice 
The findings from this study emphasises the need for proper assessment of dialysis patient’s 
medication-taking behaviour during routine dialysis to ensure the benefits of prescribed 
therapies. Recognition of medication nonadherence in patients will allow healthcare providers 
and patients to make a collaborative effort in developing patient-specific tailored solutions to 
address the problem of medication nonadherence. 
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What does this paper contribute to the wider global clinical community? 
 
• Little is known about the renal nurses’ practices of assessing medication adherence 
during the routine care of patients undergoing dialysis. 
• Renal nurses rely on routine laboratory results to detect medication nonadherence, 
with little to no attention being paid to patient engagement via self-reported measures. 
• Lack of time, lack of support from hospital administration, and patients’ disinterest in 
communicating medication-related issues to renal nurses were perceived as barriers to 
assessing adherence. 
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Table 1. Demographics of survey respondents (n = 113) 
Variable Category n (%) 
Age, Years  47 (range, 25-66) 
 20-30 6 (5.3) 
 31-40 24 (21.2) 
 41-50 39 (34.5) 
 ≥ 51 44 (38.9) 
Gender   
 Male 9 (8.0) 
 Female 104 (92.0) 
Level of education   
 Diploma 11 (9.7) 
 Bachelors 48 (42.5) 
 Graduate certificate 46 (40.7) 
 Masters and doctorate  8 (7.1) 
Designation   
 Enrolled Nurse 2 (1.8) 
 Registered Nurse 76 (67.3) 
 Nurse Practitioner 7 (6.2) 
 Nurse Unit Manager 28 (24.8) 
Experience in renal unit, Years  14 (range, 1-36) 
  1-10 43 (38.1) 
  11-20 54 (47.8) 
  ≥ 21 16 (14.2) 
Australian Territory   
 Victoria 55 (48.7) 
 Queensland  16 (14.2) 
 Tasmania 16 (14.2) 
 New South Wales  13 (11.5) 
 Other States  13 (11.5) 
Organization type   
 Public 99 (87.6) 
 Private 14 (12.4) 
Dialysis unit location   
 Metropolitan 52 (46.0) 
 Rural 61 (54.0) 
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Characteristics of dialysis unit   
 Number of dialysis chairs (n = 111) 12 (range, 3-32) 
 Number of 1.0 FTE nurse (n = 79) 4 (range, 1-16) 
 Presence of nursing educator, Yes 49 (43.4), 0.6 FTE (range, 0.3-1.0) 
 Presence of pharmacist, Yes 25 (22.1), 1.0 FTE (range, 0.4-1.0) 
 In-centre haemodialysis service (HD) 83 (73.5) 
 Peritoneal dialysis service (PD) 2 (1.8) 
 Home haemodialysis (Home HD) 1 (0.9) 
 All  services (HD, Home HD, PD)  27 (23.9) 
Note: For continuous variables, median (range); for categorical variables, numbers with percentage in 
parentheses; Abbreviation: FTE, full-time equivalent of service 
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Table 2. Perceived prevalence and contributors of nonadherence in dialysis patients 
Statements Participant’s Response (%) Median (IQR) 
Perceived prevalence Scoring ≤ 5 Scoring ≥ 6  
Have limited understanding of their medications (n = 112) 42.9 57.1 6 (4-8) 
Rarely ask questions about medications (n = 112) 34.8 65.2 7 (4-8) 
Do not take their medications as prescribed (n = 112) 44.6 55.4 6 (4-7) 
Stop taking some medications when feel better (n = 111) 47.7 52.3 6 (3-7) 
Are often confused about medicines (n = 111) 37.8 62.2 7 (5-8) 
Change dose/dosing interval that suits l ifestyles (n = 111) 48.6 51.4 6 (3-7) 
Express difficulty in swallowing larger pil ls (n = 111) 45.9 54.1 6 (3-8) 
Don’t believe current medicines are helping (n = 111) 66.7 33.3 4 (3-6) 
Can’t answer questions about medications (n = 111) 36.0 64.5 7 (4-8) 
Forget to take medications sometimes (n = 110) 25.5 74.5 8 (5-9) 
Perceived contributors    
Older patients are more nonadherent (n = 110) 82.7 17.3 4 (2-5) 
Male patients are more nonadherent (n = 110) 67.3 32.7 5 (3-7) 
Patients with multiple co-morbidities (n = 109) 43.1 56.9 6 (5-8) 
Patients lacking family/social support (n = 109) 28.4 71.6 7 (5-8) 
Patients having low income (n = 109) 35.8 64.2 7 (5-8) 
Patients having low level education background (n = 109) 29.4 70.6 7 (5-8) 
Having different language/cultural background (n = 108) 34.3 65.7 7 (5-8) 
Having l imited understanding of disease state (n = 109) 22.0 78.0 7 (6-8) 
Patients not satisfied with their treatment/care (n = 109) 40.4 59.6 6 (4-8) 
Patients with complex medication regimens (n = 109) 28.4 71.6 7 (5-9) 
Note: Perception measured on a scale of 1-10, where 1 = strongly disagree and 10 = strongly agree; n 
represents number of participants responding to each item in a questionnaire; Abbreviation: IQR, Inter-
quartile range. 
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Table 3. Perceived effectiveness, barriers and confidence to assess adherence in dialysis 
patients 
Statements Participant’s Response (%) Median (IQR) 
Perceived effectiveness Scoring ≤ 5 Scoring ≥ 6  
Interviewing patients to obtain medication history (n = 108) 17.6 82.4 8 (6-9) 
Asking patient’s family/carer about medication (n = 108) 13.0 87.0 7 (6-8) 
Measuring objective indicators such as SPL/BP (n = 108) 13.0 87.0 8 (7-9) 
Asking patients to bring medications and count (n = 107) 42.1 57.9 7 (4-8) 
Having a dedicated professional to take medication history (n = 
108) 
11.1 88.9 8 (7-9) 
Conducting medication reviews and reconcil iation by 
Pharmacist (n = 108) 
13.0 87.0 9 (8-10) 
Perceived barriers    
Lack of knowledge and skil ls to assess nonadherence (n = 108) 88.9 11.1 2 (2-3) 
Lack of time (n = 108) 62.0 38.0 4 (2-7) 
Not my role (n = 106) 94.4 5.6 2 (1-3) 
Patient’s disinterest on discussing medication issues (n = 108) 75.9 24.1 3 (2-5) 
No support from hospital administration (n = 106) 62.3 37.7 5 (2-8) 
Never thought about adherence before this survey (n = 108) 93.5 6.5 1 (1-2) 
Participants’ confidence     
Abil ity to conduct a medication history interview (n = 108) 14.8 85.2 8 (7-9) 
Abil ity to provide medication counsell ing (n = 108) 19.4 80.6 8 (6-9) 
Abil ity to clarify patient’s medication queries (n = 108) 15.7 84.3 7 (6-9) 
Abil ity to suggest strategies to improve adherence (n = 108) 7.4 92.6 8 (7-9) 
Abil ity to assess patient’s knowledge and beliefs about 
medications (n = 108) 
13.0 87.0 8 (7-9) 
Note: Perception measured on a scale of 1-10, where 1 = strongly disagree and 10 = strongly agree; n 
represents number of participants responding to each item in a questionnaire; Abbreviation: IQR, Inter quartile 
range; SPL, serum phosphate levels; BP, blood pressure. 
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Table 4. Differences in perceptions based on study demographics across all scales   
Variables Perceived 
prevalence  
Perceived 
contributors  
Perceived 
effectiveness  
Perceived barriers  Participants’ 
confidence  
 Median Mean 
Rank 
Median Mean 
Rank 
Median Mean 
Rank 
Median Mean 
Rank 
Median Mean 
Rank 
Age, years a           
20-30 7 76.3 7 55.2 9 73.3 5 93.1** 7 33.9 
31-40 6 53.7 7 60.7 8 56.2 3 62.9 8 54.2 
41-50 6 54.8 7 54.3 8 58.0 2 49.2 8 56.2 
≥ 51 6 56.8 7 53.7 8 48.3 2 49.8 8 55.6 
Gender b           
Male 6 52.7 7 59.8 8 58.6 2 48.6 7 57.0 
Female 6 56.8 7 55.2 8 54.2 3 55.0 8 54.3 
Level of education a           
Diploma 6 49.7 6 42.4 7 38.6 3 51.8 7 38.5 
Bachelors 6 51.2 7 55.3 8 61.3 3 54.2 8 55.7 
Graduate certificate 7 60.0 7 57.7 8 49.4 3 57.0 8 55.2 
Masters and doctorate  8 78.1 7 63.1 8 63.1 2 46.1 8 63.6 
Designation a           
Registered nurse 6 56.7 7 59.9* 8 54.8 3 54.1 8 51.7 
Nurse practitioner 6 44.3 5 42.1 7 32.3 4 69.7 7 45.7 
Nurse unit manager 7 55.2 5 43.5 8 55.5 2 47.8 8 60.3 
Experience in renal 
unit, Years a 
          
1-10 6 54.8 7 56.8 8 55.6 3 60.8 7 45.2* 
11-20 7 60.5 7 80.6 8 55.4 2 48.6 8 59.7 
≥ 21 6 47.1 6 56.0 8 48.2 3 58.4 8 62.3 
Note: Perception measured on a scale of 1-10, where 1 = strongly disagree and 10 = strongly agree; in cases 
where two or more groups have equal medians, the distribution of these groups is represented by mean rank.    
a Kruskal-Wallis Test. b Mann-Whitney Test. 
* P < 0.05; ** P < 0.01 
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Figure legends 
 
Figure 1. Nurses’ reports on current practices of assessing medication adherence in dialysis 
patients in Australia 
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Appendix 1. Inter-item correlation matrix and Cronbach’s alpha coefficients for each scale 
 
Prevalence scale 1 2 3 4 5 6 7 8 9 10 
1. Have l imited understanding 
of medications  
0.85          
2. Rarely ask questions about 
medications  
0.59** 0.85         
3. Do not take their 
medications as prescribed  
0.46** 0.32** 0.83        
4. Stop taking some 
medications when feel better  
0.24* 0.17 0.52** 0.83       
5. Are often confused about 
medicines  
0.49** 0.50** 0.60** 0.53** 0.82      
6. Change dose/dosing 
interval that suits l ifestyles  
0.12 0.22* 0.48** 0.37** 0.32** 0.85     
7. Express difficulty in 
swallowing larger pil ls  
-0.06 -0.01 0.35** 0.43** 0.35** 0.29** 0.86    
8. Do not believe current 
medicines are helping them  
0.16 0.16 0.30** 0.53** 0.40** 0.28** 0.51** 0.84   
9. Can’t answer questions 
about current medications  
0.57** 0.46** 0.36** 0.43** 0.71** 0.10 0.21** 0.38** 0.83  
10. Forget to take 
medications sometimes  
0.34** 0.26** 0.56** 0.59** 0.58** 0.45** 0.35** 0.43** 0.52** 0.83 
Note: Bold values indicates Cronbach’s alpha coefficients if item deleted. 
**. Correlation is significant at p < 0.01 level (2-tailed). 
*. Correlation is significant at p < 0.05 level (2-tailed). 
 
 
Contributors scale 1 2 3 4 5 6 7 8 9 10 
1. Older patients are more 
nonadherent  
0.84          
2. Male patients are more 
nonadherent  
0.45** 0.83         
3. Patients with multiple co-
morbidities  
0.23* 0.19** 0.83        
4. Patients lacking 
family/social support  
0.19* 0.30** 0.30** 0.80       
5. Patients having low income 
 
0.21* 0.23* 0.33** 0.67** 0.81      
6. Patients having low level 
education background  
0.18 0.33** 0.29** 0.66** 0.67** 0.80     
7. Having different 
language/cultural background  
0.06 0.05 0.36** 0.44** 0.38** 0.47** 0.83    
8. Having l imited 
understanding of disease 
state  
0.08 0.25** 0.21* 0.64** 0.47** 0.63** 0.38** 0.81   
9. Patients not satisfied with 
their treatment/care  
0.09 0.22* 0.04 0.29** 0.15 0.22* 0.16 0.39** 0.84  
10. Patients with complex 
medication regimens  
0.13 0.28** 0.39** 0.55** 0.50** 0.49** 0.32** 0.69** 0.45** 0.80 
Note: Bold values indicates Cronbach’s alpha coefficients if item deleted. 
**. Correlation is significant at p < 0.01 level (2-tailed). 
*. Correlation is significant at p < 0.05 level (2-tailed). 
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Effectiveness scale 1 2 3 4 5 6     
1. Interviewing patients to obtain 
medication history  
0.66          
2. Asking patient’s family/carer about 
medication  
0.41** 0.58         
3. Measuring objective indicators such as 
SPL/BP  
0.17 0.31** 0.65        
4. Asking patients to bring medications 
and count  
0.07 0.40** 0.29** 0.65       
5. Having a dedicated healthcare 
professional (Nurse/ Doctor/Pharmacist) 
to take medication history  
0.23* 0.39** 0.18 0.29** 0.58      
6. Medication reviews and reconcil iation 
by pharmacist  
0.16 0.17 0.09 0.16 0.59** 0.64     
Note: Bold values indicates Cronbach’s alpha coefficients if item deleted. 
**. Correlation is significant at p < 0.01 level (2-tailed). 
*. Correlation is significant at p < 0.05 level (2-tailed). 
 
 
Barriers scale 1 2 3 4 5 6     
1. Lack of knowledge and 
skil ls to assess nonadherence  
0.64          
2. Lack of time  0.47** 0.61         
3. Not my role  0.37** 0.27** 0.69        
4. Patient not interested in 
discussing medication issues  
0.22* 0.29** 0.26** 0.67       
5. No support from hospital 
administration  
0.43** 0.49** 0.19 0.35** 0.65      
6. Never thought about 
adherence before this survey  
0.25** 0.29** 0.19 0.22* 0.05 0.71     
Note: Bold values indicates Cronbach’s alpha coefficients if item deleted. 
**. Correlation is significant at p < 0.01 level (2-tailed). 
*. Correlation is significant at p < 0.05 level (2-tailed). 
 
 
Confidence scale 1 2 3 4 5      
1. Abil ity to conduct a 
medication history interview  
0.88          
2 .Abil ity to provide 
medication counsell ing  
0.74** 0.87         
3. Abil ity to clarify patient’s 
medication queries 
0.62** 0.77** 0.88        
4. Abil ity to suggest strategies 
to improve adherence 
0.63** 0.61** 0.60** 0.89       
5. Abil ity to assess patient’s 
knowledge and beliefs about 
medications  
0.63** 0.57** 0.62** 0.72** 0.89      
Note: Bold values indicates Cronbach’s alpha coefficients if item deleted. 
**. Correlation is significant at p < 0.01 level (2-tailed). 
*. Correlation is significant at p < 0.05 level (2-tailed). 
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Appendix 2. Comments on perceptions and current practices  
Themes Exemplar quotes 
Lack of sustainable strategy for empowering self-management 
- Medication 
self-
management 
Nonadherence also includes poor management of having their medications 
available to them at all  times, places etc. It is not the patients' intention to be 
nonadherent. Sometimes it's just difficult to take all  medications at all times. In 
fewer cases, patients intentionally do not take their medication for reasons such 
as; they think they do not need it, it's not doing anything, they don't know what 
it's for, or due to the side effects. It's the nurses who may be able to change 
these latter habits. N104 
 Lack of acknowledgment of pts need to have individual self-management 
strategies and various different approaches to empowering self-management. 
N94 
 Lack of chronic conditions self-management strategies and lack of abil ity to 
empower self-management that is truly patient centred (staff). N94 
- Adjusting to 
l ifestyles 
Mostly younger pts adjust their medications to what suits them or how they feel. 
N55 
 Not taking meds as prescribed is l imited i.e. long term younger patients are more 
l ikely to adjust tablets i .e.  Antihypertensive. N29 
- Priority of l ife 
events 
Stressful home situations mean that their own life is put on hold as they are 
more worried about others and medications isn't a priority. N14 
- Disinterest  Have found that the patients who are most non-adherent, are the ones not 
interested in learning about them. N93 
 They do receive enough education and support from our health system. 
However, they do not follow instructions or/and are compliable with 
medications and haemodialysis. N108 
- Respect to 
choice 
Some of our home patients make well informed decisions about their 
medications that we don't necessarily agree with! Sometimes we have to agree 
amongst ourselves with the medical staff as well, to respect their choices. N18 
Knowledge and understanding about medicines 
- Limited 
understanding 
of medicines 
Some patients do not take phosphate binders correctly - e.g. they don't take 
with food. The way these are prescribed sometimes says TDS rather than take 
with food. N19 
 Some patient even don't know what medication they are supposed to take. N27 
 Often patients need to know that binders need some flexibility according to 
when they eat. N36 
 Our 2 older patients have very l ittle understanding/ interest/ control in their 
medications. They leave it all  to their wives. N41 
- Good 
understanding 
of medicines 
If patients have a good understanding about why they need to take their 
prescribed medications and the consequences of not doing so, adherence 
probably increases. Blood results help as then they can see what happens if they 
don't take their medications and it reinforces the reasons for taking them. N45 
 This cl inic has all Patients who are interested in their health and well-being. Their 
understanding to their medication is good. N6 
 Pts in our dialysis unit are very informed regarding their medications…. Potential 
for future transplant used as a motivator. N114 
- Lack of 
tolerabil ity or 
perceived 
benefit 
Difficult for patients to comprehend well enough that the long term outcomes 
are worse than taking a large tablet load now i.e. PO4 binders. N68 
 Phosphate binders to be had with meals is often omitted by the patients. N60 
 My patients are very empowered about their meds especially binders. N56 
 Phosphate binders have the poorest compliance. 
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 Main problems are with Phosphate binders: Forget, avoid and wrong timing is 
frequent despite continuing education by dialysis nurses. N37 
 A lot of patients find it difficult to adhere to their phosphate binder regimens. 
Those with Webster packs are generally compliant, but definitely less 
knowledgeable about their meds. Non-adherence tends to be higher with 
phosphate binders. N92 
 Generally medications taken as prescribed agent for e.g. phosphate binders and 
other meds due at 'odd' times during the day. N106 
Clinic locations 
- Long waiting 
times for 
consultation 
As we are a satell ite dialysis unit, we do not have a renal doctor on site to 
answer pts medication questions as they arise. they wait a long time between 
renal cl inic appointments and often forget their questions about medications 
before they attend. N64 
Lack of discharge counselling 
 When patient discharge no clearly explain or remind them any change or what 
medication they should continuous. 
 Lack of health l iteracy (patients). N94 
Professional competence and trust 
- Perceived 
competence 
Many patients will  only l isten to information about medication compliance from 
their renal doctor or GP. They do not accept the information from a nurse with 
the same degree of weight or respect. N64 
- Professional 
trust 
Staff attitude is very dictatorial and non-adherence is viewed as 'deviant" thus 
pts often provide the answers they think the staff wants to hear and the true 
discussion of why non-adherence occurs hardly ever occurs as pts fear being 
labelled as 'deviant'. N94 
 Pts will  frequently tell  you they are taking their medicines when in fact they are 
not. N63 
 At times feel the patients just say they forgot or yes I’m taking them, only to see 
their blood results tells us they are not. N71 
Relative affordability 
 The cost of medications is an issue for some, their medicines run out and they 
don't have any money to buy them. N65 
 Pts with low income tend to use old medications before swapping to new 
prescription due to cost. N103 
 People let their scripts run out, don't see a GP to renew them and often tell  the 
dialysis nurse when they have already run out. This is often the case for 
indigenous patients. N57 
 Blister packs are helpful, but many can't/won't pay the extra needed to have 
them provided.  On the other hand, having blister packs often do not help with 
phosphate binders. Difficult even with a pharmacist input. N8 
Prescription refil l Failure to fi l l  script at pharmacy resulting in no medication to be taken. N14 
Culture and communication barriers 
 Indigenous status is a good indicator of overall  health status. N21 
 Increased number of patients l ive in aged care facil ity, they receive good care 
but can cause confusion with duplication and communication regarding 
medication. N95 
Forgetfulness, role of dose administration aid and support 
- Forgetfulness There is a high number of elderly patients in our unit, a lot of them don’t seem 
to retain much information or forget quite easily what was told to them. N44 
 Forgetfulness is a factor. N68 
 Patients not always good with memory but if they have meds with them, this 
might be better. Probably would forget, counting doesn't reveal when or how 
they took them. N12 
- Decreased 
cognitive 
function 
Regarding l imited understanding, it has more to do with their cognitive state, not 
their knowledge of the disease. N8 
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- Role of 
reminders 
Tablet load is a factor. Difficult to generalize here, but people with low 
education, difficult culture, language etc. are assisted by using dosettes etc. N68 
 Patients bringing in medications (Webster packs) do present usually reflect good 
adherence. 
 Webster packs assist. N112 
 Getting a copy of Webster pack medication l ist for people on multiple 
meds/elderly/memory issues. N93 
Role of comorbid illness 
- Comorbid 
i l lness 
Diabetics seem to be the most affected by non-adherence. N31 
 Diabetics the most non-compliant with medications. N31 
 Often with so many co morbidities medications themselves are making the 
patients feel unwell. N36 
- Tablet burden Some patient's express frustration at having to take so many tablets, especially 
phosphate binders. N45 
 Large pil l  load doesn't help. N65 
 Many have polypharmacy and this can add to their confusion over medication 
but also the taking of them, they just would l ike to sit and eat a meal without 
having to take a cupful of medicines. N8 
 Patients have so many tablets to take. They require large amounts of water to 
take them (eats into their fluid restriction) Some meds need to be chewed (not 
palatable). Often meds in blister packs and don't correspond with times meds 
need to be taken (binders). N79 
- Recent 
changes with 
medicines 
Patients often get confused, particularly when there are dosage changes.  Asking 
them to bring in their medications and to show you what they are taking can 
highlight variances between what they have been prescribed. N8 
Need for designated renal pharmacists 
Lack of designated 
renal pharmacists 
Have been requesting a renal pharmacist for years! N20 
 All  other department in this hospital have a dedicated pharmacist but not the 
dialysis unit. N89 
 I'm the pharmacist. Much as we would l ike to have a dedicated healthcare 
professional to deal with these issues we don't have one. N86 
 Rarely see the pharmacist and do not see her giving pts education. N57 
 There is no staff development nose attached to my hospital as it was thought we 
did not need one specific to the dialysis unit. We share the SND from the next 
ward but they are flat out, stressed and one has just resigned. For a major 
teaching hospital it is shocking. N57 
 Attempting to get a pharmacist for Dialysis... Currently available for inpatients .... 
Able to contact them, however very l imited service... N29 
 I often ring pharmacy to check when last obtained. N71 
 Don't have a pharmacist connected to unit. N58 
 We have an excellent relationship with community pharmacist which potent a 
use as a resource tool. N56 
 Our patients use different pharmacies and our hospital pharmacists does not see 
our pts. N65 
 We don't have a pharmacist on site here, but in other areas where I worked this 
was very helpful & reassuring to patients. N18 
 Ideally dedicated healthcare professionals should be engaged in medication 
history taking and reviews but doesn't happen in the dialysis unit. Most patients 
are assessed at cl inic or nephrologists' appointments only. N11 
 A pharmacist goes through medications if patient has been in hospital. Prior to 
discharge. Not done routinely with O.P. N79 
 We used to spend a lot of time doing up med profiles and getting patients to 
bring in their medications and l iaising with local pharmacies. This was very time 
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consuming and patients wouldn't bother to tell  you when a medication was 
changed. We now rely on local pharmacies to send a copy of medication profile 
to us. N16 
 Including pharmacist in medication reviews only in inpatients. N13 
Perceived barriers 
- Lack of time Time is poor on a typical nursing shift, particularly as nurses seem to take on 
every increasing roles and responsibilities. Medication is, however, as essential 
component of thorough and holistic nursing care. I find that some patients find it 
boring or repetitive to discuss medications, so perhaps it should not be done too 
often. N104 
- Lack of 
training 
Lack of training for renal nurses in this area. N94 
 I have been working in renal system for few years. I have a lot of knowledge of 
renal medicines. However, I sti l l feel myself need more comprehensive study and 
in services. There will  be helpful to have self-learning package. N108 
- Staff shortage When the above actions are combined, it may make a difference, but difficult to 
achieve with patient/professional ratios. N104 
Multidisciplinary role 
 How to build up the beliefs of medication and is more important haemodialysis 
will  give them better health outcomes. Of course the better health outcome 
could bring them normal l ife and enjoy l ife. I think the social worker should be 
involved more. N107 
 More social worker input and regularly interview and blood tests for patients. 
N108 
- Role of nurse It is part of the dialysis nurse role to help pts with education and understanding 
of adherence to medication regimen. N68 
 Discussing/liaising/monitoring pts meds/pathology and reporting to RMO as 
integral part of a renal nurse role. N106 
 Need to initiation for nursing staff on coordination whenever 
medication/dosage/pathology-this info needs to be consistently fed back to the 
patients. N106 
Ongoing education 
 I always talk to my patients regarding their medications and if they take them or 
not. If I am not sure about any of their medication, I'l l  search to found out. N15   
 We util ise a monthly 'report card' to discuss pathology results and potential to 
improve outcomes i.e. taking meds at appropriate times... N29 
 We take routine blood pre- and post- dialysis every month and then the nurse 
unit manager, nurse practitioner, pharmacist, and renal nephrologist meet to 
discuss the results and make any relevant changes to the patient's medications 
based on these results. The clinical nurse or nurse unit manager then goes to 
each patient to discuss the blood results and talk about their medications plus 
adherence to these. N45 
Current practices 
 Serum PO4 and BP are not solely done to check med compliance, but are 
routinely done on all  patients. Poor results act as a flag for checking medications. 
Interviewing for med history is meant to be done for all  patients - not always 
attended. N93 
 Unless symptomatic, medication history not reviewed. Education more l ikely to 
change behaviours but not identifying issues unless problem arise. N12 
 We ask patients to bring in their meds, but we don't count them to see how 
many they have taken.  We treat them as adults and therefore educate them 
regarding how and when to take.  They have to take some responsibility unless 
they have other medical/psycho social issues that impact on this. N8 
Note: N = Nurse participant (with a number to indicate the participant ID for example, N5 is the fifth respondent).  
